InsiderClue
← All stocks

Olema Pharmaceuticals, Inc.

OLMA Net selling
CIK 0001750284 #2588 in the set updated 20 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$24.74M
$0.00 on a plan · $19.18M straight out of an exercise
Sold at will
$5.56M
11 of 25 sales
Net
−$24.74M
−$5.56M against sales at will

By person

12 insiders · 26 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
CLARK IAN T
Director
—
$7.87M (3) scheduled
−$7.87M
0
0.0000%
$0.00
—
Zojwalla Naseem
CHIEF MEDICAL OFFICER
—
$7.53M (4) scheduled
−$7.53M
4,488
0.0051%
$52.57K
−95.3%
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
—
$4.66M (8) scheduled
−$4.66M
687,607
0.7859%
$8.05M
−6.4%
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
—
$2.98M (2)
−$2.98M
139,727
0.1597%
$1.64M
−71.2%
Mitchell Shawnte
CHIEF LEGAL OFFICER
—
$951.50K (3) scheduled
−$951.50K
0
0.0000%
$0.00
—
Harmon Cyrus
Director
—
$743.76K (5)
−$743.76K
819,798
0.9369%
$9.60M
−6.1%
Bain Capital Life Sciences Investors, LLC entity
10% owner
—
—
—
4,300,000
4.91%
$50.37M
−42.7%
Graham G. Walmsley
Director
—
—
—
1,408,875
1.61%
$16.50M
−49.9%
BVF PARTNERS L P/IL entity
Director
—
—
—
347,970
0.3977%
$4.08M
−91.6%
Bohen Sean
PRESIDENT AND CEO
—
—
—
237,650
0.2716%
$2.78M
+57.5%
Austin Sasha Lu
VP of Finance and Controller
—
—
—
16,188
0.0185%
$189.63K
+260.7%
RAPPAPORT ANDREW
Director
—
—
—
0
0.0000%
$0.00
—

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Mitchell Shawnte
4 Mar 2026
CHIEF LEGAL OFFICER
Sold after exercise
233
$24.69
$5.75K
Mitchell Shawnte
4 Mar 2026
CHIEF LEGAL OFFICER
Sold after exercise
24,767
$24.25
$600.60K
Mitchell Shawnte
3 Mar 2026
CHIEF LEGAL OFFICER
Sold after exercise
15,000
$23.01
$345.15K
Myles David C.
14 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sold after exercise
35,003
$28.99
$1.01M
Myles David C.
14 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sold after exercise
14,997
$28.60
$428.91K
Myles David C.
13 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sold after exercise
200
$28.49
$5.70K
Myles David C.
13 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sold after exercise
49,800
$27.60
$1.37M
Zojwalla Naseem
23 Dec 2025
Chief Medical Officer
Sold after exercise
99,509
$27.66
$2.75M
Zojwalla Naseem
22 Dec 2025
Chief Medical Officer
Sold after exercise
100,000
$28.04
$2.80M
Zojwalla Naseem
19 Dec 2025
Chief Medical Officer
Sold after exercise
12,921
$28.93
$373.80K
Zojwalla Naseem
19 Dec 2025
Chief Medical Officer
Sold after exercise
57,079
$28.03
$1.60M
CLARK IAN T
19 Dec 2025
Director
Sold after exercise
41,840
$30.48
$1.28M
CLARK IAN T
19 Dec 2025
Director
Sold after exercise
193,056
$29.71
$5.74M
CLARK IAN T
19 Dec 2025
Director
Sold after exercise
29,904
$28.83
$862.13K
Show all 26 transactions →

What was left out

Form 4 filings counted 32
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 14
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 945,736
History held since 19 Nov 2020